| Original language | English |
|---|---|
| Pages (from-to) | 519-522 |
| Number of pages | 4 |
| Journal | European Urology |
| Volume | 84 |
| Issue number | 6 |
| Early online date | 12 Sept 2023 |
| DOIs | |
| Publication status | Published - Dec 2023 |
Bibliographical note
Funding Information:The updated European Council recommendation emphasizes the importance of a stepwise approach involving pilot programs and further research to assess the feasibility and effectiveness of an organized screening program for prostate cancer [9] . These pilot programs should invite men at risk and apply individual retesting intervals, using PSA testing for initial screening and follow-up tests with risk calculators and magnetic resonance imaging before biopsy. In addition, the limited number of men diagnosed with low-risk disease should be discouraged from choosing to undergo active therapy. As part of this effort, the European Commission launched a call for proposals for the initiative under the EU4Health program with a specific focus on prostate cancer screening. The European Association of Urology, together with consortium partners, submitted a proposal for the PRAISE-U (Prostate Cancer Awareness and Initiative for Screening in the European Union) project, which was selected by the European Commission for receipt of funding under the EU4Health program ( Fig. 1 ).
Funding Information:
Disclaimers: This project has received funding from the EU4Health program under grant agreement 101101217, co-funded by the European Union. The views and opinions expressed are those of the author(s) alone and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer/World Health Organization.
